CClinicalTrials.gg
CompletedNCT03100383Updated Apr 4, 2017

Influence of Medical Nutrition Therapy and Eating Behavior on Gestational Weight Gain

An observational study in Weight Gain and Eating Behavior, sponsored by Materno-Perinatal Hospital of the State of Mexico. Completed. Open to female participants. Per ClinicalTrials.gov, last updated 2017-04-04.

Sponsored by Materno-Perinatal Hospital of the State of Mexico · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
57
Sex
Female
01

Study summary

To assess the association of the number of medical nutrition therapy (MNT) consultations and eating behavior (cognitive restraint, uncontrolled eating, and emotional eating) with GWG in women with type 2 diabetes mellitus (T2DM) and gestational diabetes mellitus (GDM).

Read the detailed description

Women in puerperium with known T2DM or GDM diagnosed at the hospital were invited to participate in the study. Gestational diabetes was diagnosed with a 75-g oral glucose tolerance test. Weight (kg) and height (m) were measured using a mechanical column scale (SECA).

The specific dimensions of eating behavior were measured through the 18-item Three-Factor Eating Questionnaire-18 (TFEQ-18).

The Medical Nutrition Therapy (MNT) was offered every 2-4 weeks. This therapy consists of providing a food plan with the following recommendations: limiting carbohydrate intake to 35-45% of total calories calculated as 30 kcal/kg based on pregestational BMI for an ideal weight .

We evaluated the effect of MNT on GWG using a multiple linear regression model

02

Conditions studied

  • Weight Gain
  • Eating Behavior

Keywords

  • gestational diabetes
  • Type2 Diabetes
03

In context

Body Weight

1,223 studies on the registry are indexed under Body Weight; 131 are open to participants now.

This study's enrollment of 57 is below the median of 140 across 238 observational studies indexed under Body Weight.

Browse Body Weight studies →

Lead sponsor

Materno-Perinatal Hospital of the State of Mexico is the lead sponsor of 12 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Women in puerperium with known T2DM or GDM diagnosed at the hospital were invited to participate in the study.

Inclusion criteria

  • Women in puerperium with known T2DM or GDM diagnosed at the hospital.

Exclusion criteria

Exclusion Criteria:

  • Women with a twin or other multiple pregnancy, type 1 diabetes mellitus (T1DM), or intolerance to carbohydrates, and those with additional diseases (hypertensive disorders of pregnancy, hyper- or hypothyroidism, lupus, kidney or liver disease).
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
57 participants (actual)
Target follow-up
9 Months
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Gestational Weight Gain (GWG).

    GWG was calculated by subtracting the prepregnancy weight from the weight at the end of third trimester (kg).

    Time frame: 9 months

Secondary outcomes

  1. Eating behavior

    The specific dimensions of eating behavior were measured through the 18-item Three-Factor Eating Questionnaire-18.

    Time frame: 9 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 4, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03100383
Lead sponsor
Materno-Perinatal Hospital of the State of Mexico
Responsible party
Hugo Mendieta Zeron (Chief of the Research Department, Materno-Perinatal Hospital of the State of Mexico) — Principal investigator
First posted
Apr 4, 2017
Start date
Nov 1, 2013
Primary completion
Jun 1, 2014
Completion
Nov 30, 2014
Last update
Apr 4, 2017

Study contacts

Hugo Mendieta Zerón, PhD.
principal investigator · Maternal-Perinatal Hospital "Mónica Pretelini Sáenz"

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion